This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES USA: Oligonucleotide & Peptide Therapeutics


  • 00
  • 00
  • 00
  • 00
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center

Kyle Schneider, PhD
R&D Director at Vestaron


Kyle Schneider is the Director of R&D at Vestaron and is a trained structural biologist and protein engineer. Kyle received his B.S. from Grand Valley State University, M.S. from Yale University, and Ph.D. from Northwestern University and was a Postdoctoral Fellow at Genentech in the Antibody Engineering department prior to joining Vestaron in 2016. Kyle is a former Goldwater Scholar, NSF Research Fellow, and National Academy of Engineering outstanding early career engineer. He has authored numerous papers in biochemistry and structural biology, a book chapter on peptides in crop protection, as well as an analysis on the use of biopesticides for U.S. Congress. Kyle also holds six patents in peptide engineering and manufacturing and developed a novel peptide bioinsecticide currently under review for commercial application with the Environmental Protection Agency (EPA).

Agenda Sessions

  • Personalized Medicine for Agriculture – How Natural and Designed Macromolecules Are Reshaping Crop Protection and How We Grow Food